LifePoint Health (LPNT) Receives $53.21 Consensus PT from Analysts
Shares of LifePoint Health (NASDAQ:LPNT) have been assigned a consensus rating of “Hold” from the twenty-three ratings firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, thirteen have given a hold rating and seven have assigned a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $53.21.
LPNT has been the topic of several analyst reports. BidaskClub raised shares of LifePoint Health from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Robert W. Baird reissued a “buy” rating and issued a $54.00 target price on shares of LifePoint Health in a research report on Tuesday, March 27th. Morgan Stanley reissued an “equal weight” rating and issued a $46.00 target price (down from $50.00) on shares of LifePoint Health in a research report on Monday, February 26th. SunTrust Banks lowered their price objective on shares of LifePoint Health to $44.00 and set a “hold” rating on the stock in a research report on Monday, February 26th. Finally, ValuEngine downgraded shares of LifePoint Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st.
LifePoint Health stock opened at $48.95 on Wednesday. The company has a market capitalization of $1,885.55, a PE ratio of 13.48, a PEG ratio of 1.48 and a beta of 0.50. The company has a current ratio of 1.70, a quick ratio of 1.49 and a debt-to-equity ratio of 1.26. LifePoint Health has a fifty-two week low of $41.45 and a fifty-two week high of $67.95.
In other LifePoint Health news, Chairman William F. Carpenter III bought 21,368 shares of LifePoint Health stock in a transaction on Wednesday, February 28th. The stock was purchased at an average cost of $46.80 per share, for a total transaction of $1,000,022.40. Following the completion of the purchase, the chairman now directly owns 482,668 shares of the company’s stock, valued at $22,588,862.40. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 8.76% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Cerebellum GP LLC acquired a new stake in LifePoint Health in the fourth quarter valued at approximately $126,000. State of Alaska Department of Revenue acquired a new stake in LifePoint Health in the fourth quarter valued at approximately $134,000. US Bancorp DE lifted its stake in LifePoint Health by 62.4% in the fourth quarter. US Bancorp DE now owns 3,095 shares of the company’s stock valued at $155,000 after acquiring an additional 1,189 shares during the last quarter. Xact Kapitalforvaltning AB acquired a new stake in LifePoint Health in the fourth quarter valued at approximately $230,000. Finally, OxFORD Asset Management LLP acquired a new stake in LifePoint Health in the third quarter valued at approximately $303,000.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.